메뉴 건너뛰기




Volumn 122, Issue 20, 2004, Pages 789-795

Utilization of economic assessments of health interventions;Utilización de las evaluaciones económicas de intervenciones sanitarias

Author keywords

Assessment; Costs; Economics; Efficiency; Medicine

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DECISION MAKING; DRUG INDUSTRY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MEDICAL PRACTICE; MONEY; OUTCOMES RESEARCH; QUALITY CONTROL; REVIEW;

EID: 3142731610     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062670     Document Type: Review
Times cited : (18)

References (60)
  • 1
    • 0042991448 scopus 로고    scopus 로고
    • Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making
    • Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, et al. Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making. Value Health 2003;6:407-16.
    • (2003) Value Health , vol.6 , pp. 407-416
    • Drummond, M.1    Brown, R.2    Fendrick, A.M.3    Fullerton, P.4    Neumann, P.5    Taylor, R.6
  • 2
    • 0025937985 scopus 로고
    • Oregon's methods: Did cost-effectiveness analysis fail?
    • Eddy DM. Oregon's methods: did cost-effectiveness analysis fail? JAMA 1991;15:2135-41.
    • (1991) JAMA , vol.15 , pp. 2135-2141
    • Eddy, D.M.1
  • 5
    • 0003866632 scopus 로고    scopus 로고
    • Ottawa: CCOHTA
    • nd ed. Ottawa: CCOHTA, 1997.
    • (1997) nd Ed.
  • 6
    • 0012485416 scopus 로고    scopus 로고
    • Use of pharmacoeconomic data by regulatory authorities
    • Spilker B, editor. Philadelphia: Lippincott-Raven Publishers
    • Glasziou P, Mitchell A. Use of pharmacoeconomic data by regulatory authorities. En: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers, 1996.
    • (1996) Quality of Life and Pharmacoeconomics in Clinical Trials
    • Glasziou, P.1    Mitchell, A.2
  • 7
    • 0037225828 scopus 로고    scopus 로고
    • How recommendations are made
    • Ontario's Formulary Committee
    • PausJenssen AM, Singer PA, Detsky AS. Ontario's Formulary Committee. How recommendations are made. Pharmacoeconomics 2003;21:285-94.
    • (2003) Pharmacoeconomics , vol.21 , pp. 285-294
    • PausJenssen, A.M.1    Singer, P.A.2    Detsky, A.S.3
  • 8
    • 85030884717 scopus 로고    scopus 로고
    • U.K. National Health Service. National Institute for Clinical Excellence. Disponible en: www.nice.org.uk
  • 9
    • 0033539236 scopus 로고    scopus 로고
    • NICE to rule on influenza flu drug zanamivir
    • Yamey G. NICE to rule on influenza flu drug zanamivir. BMJ 1999;319:942.
    • (1999) BMJ , vol.319 , pp. 942
    • Yamey, G.1
  • 10
    • 0037270120 scopus 로고    scopus 로고
    • The fourth hurdle as controlling instrument for expenditure on medication?
    • Kulp W, Greiner W, Von der Schulenburg JM. The fourth hurdle as controlling instrument for expenditure on medication? Eur J Health Econ 2003;4:1-5.
    • (2003) Eur J Health Econ , vol.4 , pp. 1-5
    • Kulp, W.1    Greiner, W.2    Von Der Schulenburg, J.M.3
  • 11
    • 0029096271 scopus 로고
    • Economic analysis of health technologies and programes. A Spanish proposal for methodological standardisation
    • Rovira J, Antoñanzas F. Economic analysis of health technologies and programes. A Spanish proposal for methodological standardisation. Pharmacoeconomics 1995;8:245-52.
    • (1995) Pharmacoeconomics , vol.8 , pp. 245-252
    • Rovira, J.1    Antoñanzas, F.2
  • 12
    • 0043033163 scopus 로고    scopus 로고
    • Challenges to achieving values in drug spending in a decentralized country: The Spanish case
    • Antoñanzas F. Challenges to achieving values in drug spending in a decentralized country: the Spanish case. Value Health 2003;6(Suppl 1):52-63.
    • (2003) Value Health , vol.6 , Issue.SUPPL. 1 , pp. 52-63
    • Antoñanzas, F.1
  • 13
    • 3142666474 scopus 로고    scopus 로고
    • Análisis de las evaluaciones económicas de tecnologías sanitarias realizadas en España en la década 1990-2000
    • Oliva J, Del Llano J, Sacristán JA. Análisis de las evaluaciones económicas de tecnologías sanitarias realizadas en España en la década 1990-2000. Gac Sanit 2003;16(Supl 2):2-11.
    • (2003) Gac Sanit , vol.16 , Issue.SUPPL. 2 , pp. 2-11
    • Oliva, J.1    Del Llano, J.2    Sacristán, J.A.3
  • 14
    • 0035673194 scopus 로고    scopus 로고
    • Twenty years of health care economic analysis in Spain: Are we doing well?
    • García-Altés A. Twenty years of health care economic analysis in Spain: are we doing well? Health Econ 2001;10:715-9.
    • (2001) Health Econ , vol.10 , pp. 715-719
    • García-Altés, A.1
  • 15
    • 85030884437 scopus 로고    scopus 로고
    • Ley 16/2003 de 28 de mayo de cohesión y calidad del Sistema Nacional de Salud
    • Ley 16/2003 de 28 de mayo de cohesión y calidad del Sistema Nacional de Salud.
  • 16
    • 0041530262 scopus 로고    scopus 로고
    • The drug budget silo mentality in Europe: An overview
    • Garrison L, Towse A. The drug budget silo mentality in Europe: an overview. Value Health 2003;6(Suppl 1):1-9.
    • (2003) Value Health , vol.6 , Issue.SUPPL. 1 , pp. 1-9
    • Garrison, L.1    Towse, A.2
  • 17
    • 0034034660 scopus 로고    scopus 로고
    • The influence of economic evaluations studies on decision making. A European survey
    • Hoffmann C, Graf von der Schulenburg JM. The influence of economic evaluations studies on decision making. A European survey. Health Policy 2000;52:179-92.
    • (2000) Health Policy , vol.52 , pp. 179-192
    • Hoffmann, C.1    Graf Von Der Schulenburg, J.M.2
  • 18
    • 0042206385 scopus 로고    scopus 로고
    • Moving beyond the drug budget silo mentality in Europe
    • Drummond M, Jönsson B. Moving beyond the drug budget silo mentality in Europe. Value Health 2003;6(Suppl 1):74-7.
    • (2003) Value Health , vol.6 , Issue.SUPPL. 1 , pp. 74-77
    • Drummond, M.1    Jönsson, B.2
  • 19
    • 0042991448 scopus 로고    scopus 로고
    • Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making
    • Drummond M, Brown R, Fendrick AM, Fullerton P, Neumann P, Taylor R, et al. Use of pharmacoeconomics information. Report of the ISPOR Task Force on Use of Pharmacoeconomics/Health Economics Information in Health-Care Decision Making. Value Health 2003;6:407-16.
    • (2003) Value Health , vol.6 , pp. 407-416
    • Drummond, M.1    Brown, R.2    Fendrick, A.M.3    Fullerton, P.4    Neumann, P.5    Taylor, R.6
  • 20
    • 0034945594 scopus 로고    scopus 로고
    • Health economic guidelines. Similarities, differences and some implications
    • Hjelmgren J, Berggren F, Anderson F. Health economic guidelines. Similarities, differences and some implications. Value Health 2001;4:225-50.
    • (2001) Value Health , vol.4 , pp. 225-250
    • Hjelmgren, J.1    Berggren, F.2    Anderson, F.3
  • 22
    • 0037280384 scopus 로고    scopus 로고
    • Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling studies
    • Weinstein MC, O'Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices - Modeling studies. Value Health 2003;6:9-17.
    • (2003) Value Health , vol.6 , pp. 9-17
    • Weinstein, M.C.1    O'Brien, B.2    Hornberger, J.3    Jackson, J.4    Johannesson, M.5    McCabe, C.6
  • 23
    • 0037357132 scopus 로고    scopus 로고
    • A checklist for retrospective database studies. Report of the ISPOR Task Force on Retrospective Databases
    • Motheral B, Brooks J, Clark MA, Crown WH, Davey P, Hutchins D, et al. A checklist for retrospective database studies. Report of the ISPOR Task Force on Retrospective Databases. Value Health 2003;6:90-7.
    • (2003) Value Health , vol.6 , pp. 90-97
    • Motheral, B.1    Brooks, J.2    Clark, M.A.3    Crown, W.H.4    Davey, P.5    Hutchins, D.6
  • 24
    • 0037930229 scopus 로고    scopus 로고
    • Modeling the cost-effectiveness and budgetary impact for subpopulations
    • Nuijten MJC, Kosa J, Engelfriet P. Modeling the cost-effectiveness and budgetary impact for subpopulations. Eur J Health Econom 2003;4:70-8.
    • (2003) Eur J Health Econom , vol.4 , pp. 70-78
    • Nuijten, M.J.C.1    Kosa, J.2    Engelfriet, P.3
  • 25
    • 0031945970 scopus 로고    scopus 로고
    • Extrapolation of cost-effectiveness information to local settings
    • Bryan S, Brown J. Extrapolation of cost-effectiveness information to local settings. J Health Serv Res Policy 1998;3:108-12.
    • (1998) J Health Serv Res Policy , vol.3 , pp. 108-112
    • Bryan, S.1    Brown, J.2
  • 26
    • 0034995507 scopus 로고    scopus 로고
    • Developing guidance for budget impact analysis
    • Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics 2001;19:609-21.
    • (2001) Pharmacoeconomics , vol.19 , pp. 609-621
    • Trueman, P.1    Drummond, M.2    Hutton, J.3
  • 27
    • 0035586112 scopus 로고    scopus 로고
    • NICE: Faster access to modern treatments? Analysis of guidance on health technologies
    • Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 2001;323:1300-3.
    • (2001) BMJ , vol.323 , pp. 1300-1303
    • Raftery, J.1
  • 30
    • 0041807885 scopus 로고    scopus 로고
    • What is the price of life and why doesn't it increase at the rate of inflation?
    • Ubel PA. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003;163:1637-41.
    • (2003) Arch Intern Med , vol.163 , pp. 1637-1641
    • Ubel, P.A.1
  • 31
    • 0037930215 scopus 로고    scopus 로고
    • Changes in cost-effectiveness over time. The case of epoetin alfa for renal replacement therapy patients in the UK
    • Remák E, Hutton J, Zagari M. Changes in cost-effectiveness over time. The case of epoetin alfa for renal replacement therapy patients in the UK. Eur J Health Econom 2003;4:115-21.
    • (2003) Eur J Health Econom , vol.4 , pp. 115-121
    • Remák, E.1    Hutton, J.2    Zagari, M.3
  • 33
    • 0037029325 scopus 로고    scopus 로고
    • From guidance to practice: Why NICE is not enough
    • Dent THS, Sadler M. From guidance to practice: why NICE is not enough. BMJ 2002;324:842-5.
    • (2002) BMJ , vol.324 , pp. 842-845
    • Dent, T.H.S.1    Sadler, M.2
  • 34
    • 0033756058 scopus 로고    scopus 로고
    • Equity in the allocation of health care resources
    • Sheldon TA, Smith PC. Equity in the allocation of health care resources. Health Econ 2000;9:571-4.
    • (2000) Health Econ , vol.9 , pp. 571-574
    • Sheldon, T.A.1    Smith, P.C.2
  • 35
    • 0029979686 scopus 로고    scopus 로고
    • Cost-effectiveness analysis in a setting of budget constrains. Is it equitable?
    • Ubel PA, DeKay ML, Baron J, Asch DA. Cost-effectiveness analysis in a setting of budget constrains. Is it equitable? N Engl J Med 1996;334:1174-7.
    • (1996) N Engl J Med , vol.334 , pp. 1174-1177
    • Ubel, P.A.1    DeKay, M.L.2    Baron, J.3    Asch, D.A.4
  • 36
    • 0037375101 scopus 로고    scopus 로고
    • The influence of cost-effectiveness information on physicians' cancer screening recommendations
    • Ubel PA, Jepson C, Baron J, Hersey JC, Asch DA. The influence of cost-effectiveness information on physicians' cancer screening recommendations. Soc Sci Med 2003;56:1727-36.
    • (2003) Soc Sci Med , vol.56 , pp. 1727-1736
    • Ubel, P.A.1    Jepson, C.2    Baron, J.3    Hersey, J.C.4    Asch, D.A.5
  • 38
    • 3142714788 scopus 로고    scopus 로고
    • Impacto de los estudios de evaluación económica en la toma de decisiones sanitarias en el ámbito hospitalario
    • Oliva J, Del Llano J, Antoñanzas F, Juárez C, Rovira J, Figueras M. Impacto de los estudios de evaluación económica en la toma de decisiones sanitarias en el ámbito hospitalario. Gestión Hospitalaria 2000;11:171-9.
    • (2000) Gestión Hospitalaria , vol.11 , pp. 171-179
    • Oliva, J.1    Del Llano, J.2    Antoñanzas, F.3    Juárez, C.4    Rovira, J.5    Figueras, M.6
  • 40
    • 0026769778 scopus 로고
    • Cost-effectiveness analysis. Will it be accepted?
    • Eddy DM. Cost-effectiveness analysis. Will it be accepted? JAMA 1992;268:132-6.
    • (1992) JAMA , vol.268 , pp. 132-136
    • Eddy, D.M.1
  • 41
    • 85030875797 scopus 로고
    • Evaluación económica, establecimiento de prioridades y racionamiento del gasto en sanidad
    • Haymarker S.A
    • Rovira J. Evaluación económica, establecimiento de prioridades y racionamiento del gasto en sanidad. En: Toma de decisiones clínicas: de la teoría a la práctica. Haymarker S.A., 1993.
    • (1993) Toma de Decisiones Clínicas: De la Teoría a la Práctica
    • Rovira, J.1
  • 43
    • 0012555408 scopus 로고    scopus 로고
    • Los costes de las actuaciones médicas inadecuadas
    • Meneu R. Los costes de las actuaciones médicas inadecuadas. FMC Aten Primaria 2000;7:378-85.
    • (2000) FMC Aten Primaria , vol.7 , pp. 378-385
    • Meneu, R.1
  • 44
    • 0036835595 scopus 로고    scopus 로고
    • Incorporating economic analysis into clinical practice guidelines: A guide for users
    • Ramsey SD. Incorporating economic analysis into clinical practice guidelines: a guide for users. ACP J Club 2002;137:A11.
    • (2002) ACP J Club , vol.137
    • Ramsey, S.D.1
  • 45
    • 0035974488 scopus 로고    scopus 로고
    • Summarising economic evaluations in systematic reviews: A new approach
    • Nixon J, Khan KS, Kleijnen J. Summarising economic evaluations in systematic reviews: a new approach. BMJ 2001;322:1596-8.
    • (2001) BMJ , vol.322 , pp. 1596-1598
    • Nixon, J.1    Khan, K.S.2    Kleijnen, J.3
  • 46
    • 0003702642 scopus 로고    scopus 로고
    • Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid?
    • Drummond MF, Richardson WS, O'Brien BJ, Levine M. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? JAMA 1997;277:1552-7.
    • (1997) JAMA , vol.277 , pp. 1552-1557
    • Drummond, M.F.1    Richardson, W.S.2    O'Brien, B.J.3    Levine, M.4
  • 47
    • 0030925714 scopus 로고    scopus 로고
    • Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients?
    • O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA 1997;277:1802-6.
    • (1997) JAMA , vol.277 , pp. 1802-1806
    • O'Brien, B.J.1    Heyland, D.2    Richardson, W.S.3    Levine, M.4    Drummond, M.F.5
  • 49
    • 0026526874 scopus 로고
    • Cost-effectiveness analyses in the medical literature. Are the methods being used correctly?
    • Udvarheyi IS, Colditz GA, Rai A, Epstein MP. Cost-effectiveness analyses in the medical literature. Are the methods being used correctly? Ann Intern Med 1992;116:238-44.
    • (1992) Ann Intern Med , vol.116 , pp. 238-244
    • Udvarheyi, I.S.1    Colditz, G.A.2    Rai, A.3    Epstein, M.P.4
  • 50
    • 0029063563 scopus 로고
    • Economic analysis of health care technology: A report on principles
    • Task force on principles for economic analysis of healthcare technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61-70.
    • (1995) Ann Intern Med , vol.122 , pp. 61-70
  • 51
    • 0029093028 scopus 로고
    • Methodological and conduct principles for pharmacoeconomic research
    • Pharmaceutical Research and Manufacturers of America
    • Clemens K, Towsend R, Luscombe F, Mauskopf J, Osterhaus J, Bobula J. Methodological and conduct principles for pharmacoeconomic research. Pharmaceutical Research and Manufacturers of America. Pharmacoeconomics 1995;8:169-74.
    • (1995) Pharmacoeconomics , vol.8 , pp. 169-174
    • Clemens, K.1    Towsend, R.2    Luscombe, F.3    Mauskopf, J.4    Osterhaus, J.5    Bobula, J.6
  • 52
    • 0033567212 scopus 로고    scopus 로고
    • Applied pharmacoeconomics: Evaluation and use of pharmacoeconomic data from the literature
    • Sánchez LA. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. Am J Health Syst Pharm 1999;56:1630-8.
    • (1999) Am J Health Syst Pharm , vol.56 , pp. 1630-1638
    • Sánchez, L.A.1
  • 53
    • 0027363220 scopus 로고
    • Evaluation of pharmacoeconomic studies: Utilization of a checklist
    • Sacristán JA, Soto J, Galende I. Evaluation of pharmacoeconomic studies: utilization of a checklist. Ann Pharmacother 1993;27:1126-33.
    • (1993) Ann Pharmacother , vol.27 , pp. 1126-1133
    • Sacristán, J.A.1    Soto, J.2    Galende, I.3
  • 54
    • 0029143993 scopus 로고
    • Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals
    • Bradley CA, Iskedjian M, Lanctot KL, Mittmann N, Simone C, St Pierre E, et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681-9.
    • (1995) Ann Pharmacother , vol.29 , pp. 681-689
    • Bradley, C.A.1    Iskedjian, M.2    Lanctot, K.L.3    Mittmann, N.4    Simone, C.5    St Pierre, E.6
  • 55
    • 0030726292 scopus 로고    scopus 로고
    • Quality assessment of economic evaluations published in Pharmacoeconomics: The first four years (1992 to 1995)
    • Iskedjian M, Trakas K, Bradley CA, Addis A, Lanctot K, Kruk D, et al. Quality assessment of economic evaluations published in Pharmacoeconomics: the first four years (1992 to 1995). Pharmacoeconomics 1997;12:685-94.
    • (1997) Pharmacoeconomics , vol.12 , pp. 685-694
    • Iskedjian, M.1    Trakas, K.2    Bradley, C.A.3    Addis, A.4    Lanctot, K.5    Kruk, D.6
  • 57
    • 0031034580 scopus 로고    scopus 로고
    • Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain
    • Plans P. Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain. Public Health 1997;111:33-40.
    • (1997) Public Health , vol.111 , pp. 33-40
    • Plans, P.1
  • 59
    • 0025716094 scopus 로고
    • De la efectividad clínica a la eficiencia social
    • Ortún V, Rodríguez Artalejo F. De la efectividad clínica a la eficiencia social. Med Clin (Barc) 1990;95:385-8.
    • (1990) Med Clin (Barc) , vol.95 , pp. 385-388
    • Ortún, V.1    Rodríguez Artalejo, F.2
  • 60
    • 0025339544 scopus 로고
    • A clinician's guide to cost-effectiveness analysis
    • Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54.
    • (1990) Ann Intern Med , vol.113 , pp. 147-154
    • Detsky, A.S.1    Naglie, I.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.